James G. Hodge, Jr. gives incisive insights on legal threats to #vaccination, as well as lines of defense, in "Legal Underpinnings of the Great Vaccine Debate of 2025," now available on FirstView. #vaccines #VaccineEffectiveness #VaccineSafety www.cambridge.org/core/journal...
Bluesky

Bluesky Social
Eurosurveillance | Volume 29, Issue 3

eurosurveillance.org is the online home of Eurosurveillance, Europe's journal on infectious disease surveillance, epidemiology, prevention and control.

Eurosurveillance | Volume 28, Issue 24

eurosurveillance.org is the online home of Eurosurveillance, Europe's journal on infectious disease surveillance, epidemiology, prevention and control.

Eurosurveillance | Volume 28, Issue 21

eurosurveillance.org is the online home of Eurosurveillance, Europe's journal on infectious disease surveillance, epidemiology, prevention and control.

RT @Eurosurveillanc: @ECDC_Flu @ECDC_EU @NLZOH_si @ciberinfec @sciencemedia_es What was the #VaccineEffectiveness against severe #COVID19 of a second booster dose of the bivalent #mRNA vaccine, relative to a first booster dose of a monovalent #vaccine among persons ≥60 years?

Rapid communication from 🇮🇹
@istsupsan @s_brusaferro
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2023.28.8.2300105#html_fulltext

🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1629055784079224837

Eurosurveillance | Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022

Effectiveness against severe COVID-19 of a second booster dose of the bivalent (original/BA.4–5) mRNA vaccine 7–90 days post-administration, relative to a first booster dose of an mRNA vaccine received ≥ 120 days earlier, was ca 60% both in persons ≥ 60 years never infected and in those infected > 6 months before. Relative effectiveness in those infected 4–6 months earlier indicated no significant additional protection (10%; 95% CI: −44 to 44). A second booster vaccination 6 months after the latest infection may be warranted.

RT @ECDC_VPD: ECDC continues work with an extended network of countries in the EU/EEA and @Epiconcept for monitoring #VaccineEffectiveness, Burden and Impact of #COVID19 and #influenza vaccines.

🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1620796614247092224

Nature: Third dose of Moderna vaccine was more effective against infection and hospitalizations during the Delta and Omicron waves than a third dose of Pfizer vaccine. https://buff.ly/3X8q9O0

Review from EHR at Veterans Administration (> 65K ppl per group)

#Pfizer is 30 mcg vs #Moderna 100 mcg dose

#Vaccination #VaccineEffectiveness #COVID #Delta #Omicron

Comparative effectiveness of third doses of mRNA-based COVID-19 vaccines in US veterans - Nature Microbiology

Head-to-head comparison of third doses of mRNA COVID-19 vaccines in US Veterans finds that both are effective against documented SARS-CoV-2 infection and severe COVID-19 outcomes.

Nature
Eurosurveillance | Volume 27, Issue 20

eurosurveillance.org is the online home of Eurosurveillance, Europe's journal on infectious disease surveillance, epidemiology, prevention and control.